| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Najim Ameziane, PHD |
Towards the Identification of Biomarkers and Druggable Targets for FA Head and Neck Cancer |
Fanconi Anemia Research Fund |
FARF |
3/1/2016 - 2/28/2017 |
$6,500 |
| Timothy M Chlon, PHD |
Training Program in Cancer Therapeutics |
National Institutes of Health (University of Cincinnati) |
T32 CA117846 |
7/1/2015 - 6/30/2016 |
$47,244 |
| Lionel Chow, MD-PHD |
A Novel Genetically Engineered Mouse Model for Angiosarcoma: Molecular Characterization and Comparison to Human Angiosarcoma to Develop Targeted Therapy |
Sarcoma Foundation of America |
Chow, Lionel, Sarcom |
6/1/2016 - 5/31/2017 |
$50,000 |
| Lionel Chow, MD-PHD |
Molecular Targeting of Pediatric High-grade Glioma |
St. Baldrick's Foundation |
Chow, Lionel, St Bal |
7/1/2014 - 6/30/2016 |
$115,000 |
| Biplab DasGupta, PHD |
Regulation of Forebrain Neurogenesis by the Energy Sensor AMP Kinase |
National Institutes of Health |
R01 NS072591 |
7/1/2012 - 6/30/2016 |
$334,688 |
| Mariko DeWire, MD |
An early Phase 2 Study of LEE011, a CDK4/6 Inhibitor, following Radiation Therapy in Children with Newly Diagnosed Non-Biopsied Diffuse Pontine Gliomas (DIPG) and Rb+ Biopsied DIPG and High Grade Gliomas (HGG) |
The Cure Starts Now Foundation |
LEE011 |
12/1/2015 - 11/30/2016 |
$100,000 |
| Rachid Drissi, PHD |
Comprehensive Molecular-Based Cross-Species Comparison of DIPG Biology |
The Cure Starts Now Foundation (Children's National Medical Center) |
3.00E+11 |
1/1/2016 - 12/31/2016 |
$17,916 |
| Megan P Elam |
Pet Research Study conducted through the CancerFree KIDS/Impact 100 Family Pet Center at Cincinnati Children's |
Cancer Free Kids |
Elam, Megan, CFK |
7/1/2015 - 6/30/2016 |
$10,000 |
| Maryam Fouladi, MD |
Establishment of an International Diffuse Intrinsic Pontine Glioma (DIPG) Registry |
The Cure Starts Now Foundation |
DIPG - Fouladi |
1/1/2012 - 12/31/2016 |
$233,311 |
| Maryam Fouladi, MD |
COG NCTN Network Group Operations Center |
National Institutes of Health (Children's Hospital of Philadelphia) |
U10 CA180886 |
4/11/2014 - 2/28/2019 |
$7,500 |
| Maryam Fouladi, MD |
Pediatric Brain Tumor Consortium (PBTC) |
National Institutes of Health (St Jude's Children's Hospital) |
UM1 CA081457 |
4/1/2014 - 3/31/2019 |
$238,717 |
| Harry Leighton Grimes, PHD |
11th International Workshop on Molecular Aspects of Myeloid Stem Cell Development and Leukemia |
Taub Foundation Program for MDS Research |
Grimes, Leighton, Ta |
10/1/2015 - 9/30/2016 |
$25,000 |
| Adrienne Hammill, MD |
Brain Vascular Malformation Consortium: Predictors of Clinical Course |
National Institutes of Health (The Regents of the Univ of California) |
U54 NS065705 |
9/30/2014 - 7/31/2019 |
$2,106 |
| Lindsey Marie Hoffman DO |
Comprehensive Genetic Analysis of Matched Primary and Relapsed Pediatric Gliomas |
Cancer Free Kids |
Hoffman, Lindsay, CF |
7/1/2015 - 6/30/2017 |
$45,000 |
| Lindsey Marie Hoffman DO |
Intra-tumoral Heterogeneity in Diffuse Intrinsic Pontine |
The Cure Starts Now Foundation |
DIPGcollab |
11/1/2015 - 10/31/2016 |
$200,000 |
| Lindsey Marie Hoffman DO |
Comprehensive Genomic Analysis of Matched Primary and Progressive, Recurrent or Malignantly Transformed Pediatric Low Grade Giloma |
A Kids' Brain Tumor Cure Foundation |
Hoffman, Lindsay, KB |
9/1/2015 - 8/31/2016 |
$100,000 |
| Trent Hummel, MD |
Developing Evidence-based Criteria for Initiating Treatment for NF1-OPG |
The Children's Tumor Foundation |
ENDINGNF |
11/1/2015 - 10/31/2019 |
$6,600 |
| Nanki Hura |
A Contribution to the Improvement of the DIPG CARE and to the Research for the CURE |
Joshua's Wish |
hura, Nanki, joshua |
6/1/2015 - 5/31/2016 |
$5,000 |
| Benjamin Mizukawa, MD |
Targeted Inhibition of Cdc42 GTPase in the Acute Myeloid |
St. Baldrick's Foundation |
St. Bladrick_Mizukaw |
7/1/2013 - 6/30/2016 |
$110,000 |
| John P Perentesis, MD |
John Perentesis -Vice Chair AYA Committee |
American Family Life Assurance Company (Children's Hospital of Philadelphia) |
aflac |
1/1/2015 - 12/31/2018 |
$11,628 |
| John P Perentesis, MD |
NCTN BIQSFP AALL0932 |
National Institutes of Health (Children's Hospital of Philadelphia) |
U10 CA180886 |
3/1/2016 - 2/28/2019 |
$60,000 |
| Joseph Pressey, MD |
Investigation of Physical Activity in Adolescent and You |
University of Cincinnati Cancer Center |
Pressey, Joe, UCCC |
7/1/2015 - 6/30/2016 |
$50,000 |
| Lisa Marie Privette Vinnedge, PHD |
Using RNA Nanoparticles for Non-invasive Detection and Therapy of Breast Cancer |
University of Cincinnati |
Pilot |
10/1/2015 - 9/30/2016 |
$46,000 |
| Ralph Salloum, MD |
Medulloblastoma and PNET Outcomes Across Three Decades of Diagnosis |
National Institutes of Health (St Jude's Children's Hospital) |
U24 CA055727 |
12/1/2015 - 11/30/2016 |
$46,800 |
| Satarupa Sengupta, PHD |
Testing a Novel Approach to Treat Pediatric Brain Tumors |
Cancer Free Kids |
sengupta,satarupa, c |
7/1/2015 - 6/30/2017 |
$45,000 |
| Brian D Weiss, MD |
A Phase I/II Study of the Mitogen Activated Protein Kinase (MEK) 1 Inhibitor Selumetinib in Children with Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN) |
Johns Hopkins School of Medicine |
2001824052 |
1/1/2016 - 12/31/2018 |
$132,873 |
| Brian D Weiss, MD |
2014-01 phase I study of SF1126 for Patients with Relapsed or Refractory Neuroblastoma |
National Institutes of Health (Children's Hospital Los Angeles) |
P01 CA081403 |
7/7/2015 - 5/31/2017 |
$2,760 |
| Susanne Wells, PHD |
Metabolic Predictors of Childhood Cancer Development and Outcomes |
Hyundai Hope on Wheels |
34723OH |
10/1/2014 - 9/30/2016 |
$125,000 |
| Susanne Wells, PHD |
Role and Regulation of the Human DEK Proto-Oncogene |
National Institutes of Health (National Cancer Institute) |
R01 CA116316 |
9/5/2012 - 6/30/2016 |
$266,707 |
| Susanne Wells, PHD |
Targeting Lipid Metabolism in FA for the Prevention and Treatment of Squamous Cell Carcinoma |
Fanconi Anemia Research Fund |
Wells, Sue, FARF |
3/1/2016 - 2/28/2018 |
$125,000 |
| Total Annual Grant Award Dollars |
$2,566,350 |
